Transgenic rodent models utilizing human familial Alzheimer’s disease gene mutations3 have been extensively used to model various aspects of APP/Aβ pathobiology but have not proved useful in exploring the mechanisms whereby this pathobiology affects disease pathogenesis and, as a consequence, we have no effective preclinical model of sporadic Alzheimer’s disease. The gene discussed is APP; the disease is familial Alzheimer disease.